Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis

Open access

Abstract

Fibrosis is characterized by the excessive production of collagen and other extracellular matrix (ECM) components and represents a leading cause of morbidity and mortality worldwide. Previous studies of nonalcoholic steatohepatitis (NASH) with fibrosis were largely restricted to bulk transcriptome profiles. Thus, our understanding of this disease is limited by an incomplete characterization of liver cell types in general and hepatic stellate cells (HSCs) in particular, given that activated HSCs are the major hepatic fibrogenic cell population. To help fill this gap, we profiled 17,810 non-parenchymal cells derived from six healthy human livers. In conjunction with public single-cell data of fibrotic/cirrhotic human livers, these profiles enable the identification of potential intercellular signaling axes (e.g., ITGAV–LAMC1, TNFRSF11B–VWF and NOTCH2–DLL4) and master regulators (e.g., RUNX1 and CREB3L1) responsible for the activation of HSCs during fibrogenesis. Bulk RNA-seq data of NASH patient livers and rodent models for liver fibrosis of diverse etiologies allowed us to evaluate the translatability of candidate therapeutic targets for NASH-related fibrosis. We identified 61 liver fibrosis-associated genes (e.g., AEBP1, PRRX1 and LARP6) that may serve as a repertoire of translatable drug target candidates. Consistent with the above regulon results, gene regulatory network analysis allowed the identification of CREB3L1 as a master regulator of many of the 61 genes. Together, this study highlights potential cell–cell interactions and master regulators that underlie HSC activation and reveals genes that may represent prospective hallmark signatures for liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-98806-y

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation of scRNA-seq data for human liver non-parenchymal cells. (a) Workflow of sample preparation, sequencing and bioinformatic analysis. (b) UMAP visualization of single cells profiled in this study. Each dot represents a cell that is color-coded by cell type. HSCs, hepatic stellate cells; LSECs, liver sinusoidal endothelial cells; Vascular ECs, vascular endothelial cells; MDMs, monocyte-derived macrophages; NK cells, natural killer cells. (c) Representative gene expression and distribution of known marker genes for each population in UMAP plots. Normalized expression values are shown. (d) Dotplot displaying the top two marker genes for each cell type identified. Size of the dot represents proportion of the cell population that expresses each gene. Color indicates level of expression. (e) Barplot representing the relative contribution of cells from each donor for each cell type. NPC, non-parenchymal cells derived from healthy liver. (f) UMAP visualization of single cells profiled in this study together with human liver cells integrated from Ramachandran et al. (2019). (g) UMAP visualization of mesenchymal cells. The direction of cell differentiation inferred from estimated RNA velocities are plotted as streamlines on the UMAP. (h) UMAP visualization of mesenchymal cells. Cells colored by ECM score. (i) Heatmap showing the top 10 differentially expressed genes for each mesenchymal cell type. VSMCs, vascular smooth muscle cells; Meso, mesothelial cells.
Figure 1 Generation of scRNA-seq data for human liver non-parenchymal cells. (a) Workflow of sample preparation, sequencing and bioinformatic analysis. (b) UMAP visualization of single cells profiled in this study. Each dot represents a cell that is color-coded by cell type. HSCs, hepatic stellate cells; LSECs, liver sinusoidal endothelial cells; Vascular ECs, vascular endothelial cells; MDMs, monocyte-derived macrophages; NK cells, natural killer cells. (c) Representative gene expression and distribution of known marker genes for each population in UMAP plots. Normalized expression values are shown. (d) Dotplot displaying the top two marker genes for each cell type identified. Size of the dot represents proportion of the cell population that expresses each gene. Color indicates level of expression. (e) Barplot representing the relative contribution of cells from each donor for each cell type. NPC, non-parenchymal cells derived from healthy liver. (f) UMAP visualization of single cells profiled in this study together with human liver cells integrated from Ramachandran et al. (2019). (g) UMAP visualization of mesenchymal cells. The direction of cell differentiation inferred from estimated RNA velocities are plotted as streamlines on the UMAP. (h) UMAP visualization of mesenchymal cells. Cells colored by ECM score. (i) Heatmap showing the top 10 differentially expressed genes for each mesenchymal cell type. VSMCs, vascular smooth muscle cells; Meso, mesothelial cells.CC BY · PubMed Central
Figure 2 Intercellular communications in the sinusoidal signaling niche. (a) Heatmap showing the number of potential ligand-receptor pairs between any two liver cell types predicted by CellphoneDB. (b) Dotplot displaying putative ligand-receptor interactions between aHSCs and other cell types. Dot size represents statistical significance of the indicated interactions. Dot color indicates the average expression level (log2-transformed) of the receptor from aHSCs and the ligand from another cell type. (c–f) Gene expression of ITGAV, LAMC1, TNFRSF11B, and VWF at progressive disease stages. The RNA-seq data were downloaded and reanalyzed from Gerhard et al. (2018). Mann–Whitney U tests (two-sided) were performed for statistical comparisons. logCPM, log-transformed counts per million.
Figure 2 Intercellular communications in the sinusoidal signaling niche. (a) Heatmap showing the number of potential ligand-receptor pairs between any two liver cell types predicted by CellphoneDB. (b) Dotplot displaying putative ligand-receptor interactions between aHSCs and other cell types. Dot size represents statistical significance of the indicated interactions. Dot color indicates the average expression level (log2-transformed) of the receptor from aHSCs and the ligand from another cell type. (c–f) Gene expression of ITGAV, LAMC1, TNFRSF11B, and VWF at progressive disease stages. The RNA-seq data were downloaded and reanalyzed from Gerhard et al. (2018). Mann–Whitney U tests (two-sided) were performed for statistical comparisons. logCPM, log-transformed counts per million.CC BY · PubMed Central
Figure 3 Cell type-specific gene regulatory networks (regulons) of liver mesenchymal cells. (a) Heatmap of the inferred regulons for human liver mesenchymal cells. (b) Regulon activity-based UMAP colored according to the regulon activity of CREB3L1, RUNX1, TWIST1 and TWIST2 showing the cell type specificity of regulons. (c) UMAP embedding of mouse liver mesenchymal cells from uninjured and fibrotic (up to 6 weeks of CCl4 treatment) mouse livers retrieved from Dobie et al. (2019). Left, cells colored by cell type/state. Right, cells colored by condition/cell origin. (d) Heatmap of the inferred regulons for mouse liver mesenchymal cells. (e) Regulon activity-based UMAP colored by the regulon activity of Creb3l1 and Twist1 showing the cell type specificity of regulons.
Figure 3 Cell type-specific gene regulatory networks (regulons) of liver mesenchymal cells. (a) Heatmap of the inferred regulons for human liver mesenchymal cells. (b) Regulon activity-based UMAP colored according to the regulon activity of CREB3L1, RUNX1, TWIST1 and TWIST2 showing the cell type specificity of regulons. (c) UMAP embedding of mouse liver mesenchymal cells from uninjured and fibrotic (up to 6 weeks of CCl4 treatment) mouse livers retrieved from Dobie et al. (2019). Left, cells colored by cell type/state. Right, cells colored by condition/cell origin. (d) Heatmap of the inferred regulons for mouse liver mesenchymal cells. (e) Regulon activity-based UMAP colored by the regulon activity of Creb3l1 and Twist1 showing the cell type specificity of regulons.CC BY · PubMed Central
Figure 4 Comparison of expression patterns between hepatic and pancreatic stellate cells. (a) UMAP embedding of human pancreatic cells retrieved from Baron et al. (2016). Left, cells colored by cell type. Right, cells colored by donor. qPSCs, quiescent PSCs; aPSCs, activated PSCs. (b) Volcano plot of differential gene expression analysis between activated and quiescent stellate cells for liver (left) and pancreas (right). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes in activated stellate cells are shown in green and pink, respectively. 16 and 6 genes shared among the top 50 up- or down-regulated genes between liver and pancreas are labelled, respectively. (c) Heatmap of the inferred regulons for human pancreatic cells. (d) Regulon activity based UMAP colored according to the regulon activity of CREB3L1 and RUNX1 showing the cell type specificity of regulons.
Figure 4 Comparison of expression patterns between hepatic and pancreatic stellate cells. (a) UMAP embedding of human pancreatic cells retrieved from Baron et al. (2016). Left, cells colored by cell type. Right, cells colored by donor. qPSCs, quiescent PSCs; aPSCs, activated PSCs. (b) Volcano plot of differential gene expression analysis between activated and quiescent stellate cells for liver (left) and pancreas (right). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes in activated stellate cells are shown in green and pink, respectively. 16 and 6 genes shared among the top 50 up- or down-regulated genes between liver and pancreas are labelled, respectively. (c) Heatmap of the inferred regulons for human pancreatic cells. (d) Regulon activity based UMAP colored according to the regulon activity of CREB3L1 and RUNX1 showing the cell type specificity of regulons.CC BY · PubMed Central
Figure 5 Meta-analysis of existing RNA-sequencing data sets for NASH and liver fibrosis. (a) Differential gene expression analysis between fibrotic and healthy (as reference) livers. Only the top 10 up- or down-regulated genes are labelled with gene symbols. Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. (b) Computational deconvolution of bulk RNA-seq data of 191 human liver samples (normal, 36; steatosis, 50; inflammation, 52; fibrosis, 53). The RNA-seq data were retrieved from Gerhard et al. (2018). Mann–Whitney U tests (two-sided) were performed for statistical pairwise comparisons. (c) Differential gene expression analysis between aHSCs and qHSCs (as reference) isolated from healthy and fibrotic (CCl4) mouse livers. The RNA-seq data were retrieved from Marcher et al. (2019). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. Only the top 10 up- or down-regulated genes are labelled with gene symbols. (d) Differential gene expression analysis between aHSCs and qHSCs (as reference). Healthy liver-derived qHSCs were activated on plastic in vitro. The RNA-seq data were retrieved from Marcher et al. (2019). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. Only the top 10 up- or down-regulated genes are labelled with gene symbols. (e) Venn diagram showing all possible logical relations between three sets of up-regulated genes in aHSCs compared with qHSCs, and a set of up-regulated genes in bulk human fibrotic livers in comparison to healthy controls. Only the 15,252 protein-coding one-to-one orthologs for human, mouse, and rat were considered in this analysis (Supplementary Table 6). (f) Functional enrichment analysis for the 61 shared upregulated genes. (g) Regulatory gene network of the top three regulators (motifs) and their corresponding target genes among the 61 genes. (h–m) Contextualization of candidate therapeutic targets for liver fibrosis with time-course RNA-seq data. (h,i) High-fat (HF) diet-induced NASH mouse model; (j,k) Thioacetamide (TAA)-induced liver fibrosis rat model; (l,m) Bile duct ligation (BDL)-induced liver fibrosis rat model. Left, PCA of the samples studied. Right, expression levels of the genes of interest. TPM, transcripts per million. Adjusted p-values < 0.05 are colored in green.
Figure 5 Meta-analysis of existing RNA-sequencing data sets for NASH and liver fibrosis. (a) Differential gene expression analysis between fibrotic and healthy (as reference) livers. Only the top 10 up- or down-regulated genes are labelled with gene symbols. Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. (b) Computational deconvolution of bulk RNA-seq data of 191 human liver samples (normal, 36; steatosis, 50; inflammation, 52; fibrosis, 53). The RNA-seq data were retrieved from Gerhard et al. (2018). Mann–Whitney U tests (two-sided) were performed for statistical pairwise comparisons. (c) Differential gene expression analysis between aHSCs and qHSCs (as reference) isolated from healthy and fibrotic (CCl4) mouse livers. The RNA-seq data were retrieved from Marcher et al. (2019). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. Only the top 10 up- or down-regulated genes are labelled with gene symbols. (d) Differential gene expression analysis between aHSCs and qHSCs (as reference). Healthy liver-derived qHSCs were activated on plastic in vitro. The RNA-seq data were retrieved from Marcher et al. (2019). Significantly upregulated (Sig.Up) and downregulated (Sig.Down) genes are shown in green and pink, respectively. Only the top 10 up- or down-regulated genes are labelled with gene symbols. (e) Venn diagram showing all possible logical relations between three sets of up-regulated genes in aHSCs compared with qHSCs, and a set of up-regulated genes in bulk human fibrotic livers in comparison to healthy controls. Only the 15,252 protein-coding one-to-one orthologs for human, mouse, and rat were considered in this analysis (Supplementary Table 6). (f) Functional enrichment analysis for the 61 shared upregulated genes. (g) Regulatory gene network of the top three regulators (motifs) and their corresponding target genes among the 61 genes. (h–m) Contextualization of candidate therapeutic targets for liver fibrosis with time-course RNA-seq data. (h,i) High-fat (HF) diet-induced NASH mouse model; (j,k) Thioacetamide (TAA)-induced liver fibrosis rat model; (l,m) Bile duct ligation (BDL)-induced liver fibrosis rat model. Left, PCA of the samples studied. Right, expression levels of the genes of interest. TPM, transcripts per million. Adjusted p-values < 0.05 are colored in green.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 111

Metadata

Authors
Wang, Z.-Y., Keogh, A., Waldt, A., Cuttat, R., Neri, M., Zhu, S., Schuierer, S., Ruchti, A., Crochemore, C., Knehr, J., Bastien, J., Ksiazek, I., Sánchez-Taltavull, D., Ge, H., Wu, J., Roma, G., Helliwell, S. B., Stroka, D., & Nigsch, F.
Affiliations
  • University of Bern (CH)
  • Novartis (Switzerland) (CH)
Corresponding author
Nigsch, Florian
Venue
Scientific Reports
Published
2021-09-29
Volume
11
Issue
1
Pages
19396-19396
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3201984060
Cited by
103
References
80
Citations by year
2026: 14 · 2025: 19 · 2024: 21 · 2023: 35 · 2022: 14
FWCI
9.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • The Novartis Repository (Novartis) (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Access CRIS of the University of Bern
Funders
Novartis Institutes for BioMedical Research
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
nonalcoholic steatohepatitis, liver fibrosis, hepatic stellate cell activation, single-cell transcriptomics, liver cell types, extracellular matrix, intercellular communication, RUNX1, CREB3L1, master regulators, gene regulatory networks, liver cirrhosis
MeSH terms
Animals, Humans, Rats, Hepatic Stellate Cells, Single-Cell Analysis, Transcriptome, Healthy Volunteers, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. https://app.cochat.ai/papers/10.1038/s41598-021-98806-y
The paper
Wang, Z.-Y., Keogh, A., Waldt, A., Cuttat, R., Neri, M., Zhu, S., Schuierer, S., Ruchti, A., Crochemore, C., Knehr, J., Bastien, J., Ksiazek, I., Sánchez-Taltavull, D., Ge, H., Wu, J., Roma, G., Helliwell, S. B., Stroka, D., & Nigsch, F. (2021). Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Scientific Reports. https://doi.org/10.1038/s41598-021-98806-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.